Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Sax, Paul"'
Autor:
Sax P; Division of Infectious Diseases and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., DeJesus E; Orlando Immunology Center, Orlando, FL, USA., Wohl D; University of North Carolina, School of Medicine, Chapel Hill, NC, USA., DeMorin J; Medical Affairs, Gilead Sciences, Foster City, CA, USA., McColl D; Medical Affairs, Gilead Sciences, Foster City, CA, USA., Piontkowsky D; Medical Affairs, Gilead Sciences, Foster City, CA, USA., Cohen C; Medical Affairs, Gilead Sciences, Foster City, CA, USA., Wang H; Biostatistics, Gilead Sciences, Foster City, CA, USA., White K; Clinical Virology, Gilead Sciences, Foster City, CA, USA., Callebaut C; Clinical Virology, Gilead Sciences, Foster City, CA, USA., Rhee M; Clinical Research, Gilead Sciences, Foster City, CA, USA., Das M; Clinical Research, Gilead Sciences, Foster City, CA, USA., Quirk E; Clinical Research, Gilead Sciences, Foster City, CA, USA.
Publikováno v:
Antiviral therapy [Antivir Ther] 2018; Vol. 23 (1), pp. 95-99.
Autor:
Sax PE
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2013 May; Vol. 56 (9), pp. 1344-6. Date of Electronic Publication: 2013 Jan 11.
Autor:
Robbins GK; Harvard Medical School, Boston, Massachusetts, USA. grobbins@partners.org, Johnson KL, Chang Y, Jackson KE, Sax PE, Meigs JB, Freedberg KA
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2010 Mar 01; Vol. 50 (5), pp. 779-86.
Autor:
Sax, Paul E.
Publikováno v:
Clinical Infectious Diseases, 2000 Mar 01. 30(3), 511-514.
Externí odkaz:
https://www.jstor.org/stable/4461075
Autor:
Rosenberg, Eric S., Billingsley, James M., Caliendo, Angela M., Boswell, Steven L., Sax, Paul E., Kalams, Spyros A., Walker, Bruce D.
Publikováno v:
Science, 1997 Nov . 278(5342), 1447-1450.
Externí odkaz:
https://www.jstor.org/stable/2894759
Autor:
Sax, Paul E, Rockstroh, Jürgen K, Luetkemeyer, Anne F, Yazdanpanah, Yazdan, Ward, Douglas, Trottier, Benoit, Rieger, Armin, Liu, Hui, Acosta, Rima, Collins, Sean E, Brainard, Diana M, Martin, Hal, Investigators, GS-US-380–4030
Publikováno v:
Clinical Infectious Diseases; Jul2021, Vol. 73 Issue 2, pe485-e493, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jilg, Nikolaus, Garcia-Broncano, Pilar, Peluso, Michael, Segal, Florencia P, Bosch, Ronald J, Roberts-Toler, Carla, Chen, Samantha M Y, Dam, Cornelius N Van, Keefer, Michael C, Kuritzkes, Daniel R, Landay, Alan L, Deeks, Steven, Yu, Xu G, Sax, Paul E, Li, Jonathan Z, Team, AIDS Clinical Trials Group A5308 Study, Van Dam, Cornelius N, AIDS Clinical Trials Group A5308 Study Team
Publikováno v:
Journal of Infectious Diseases; Dec2020, Vol. 222 Issue 11, p1837-1842, 6p
Autor:
Saag, Michael S., Gandhi, Rajesh T., Hoy, Jennifer F., Landovitz, Raphael J., Thompson, Melanie A., Sax, Paul E., Smith, Davey M., Benson, Constance A., Buchbinder, Susan P., del Rio, Carlos, Eron, Joseph J., Fätkenheuer, Gerd, Günthard, Huldrych F., Molina, Jean-Michel, Jacobsen, Donna M., Volberding, Paul A., Eron, Joseph J Jr
Publikováno v:
JAMA: Journal of the American Medical Association; 10/27/2020, Vol. 324 Issue 16, p1651-1669, 19p
Autor:
Sax, Paul E, Wohl, David, Yin, Michael T., Post, Frank, Dejesus, Edwin, Saag, Michael, Pozniak, Anton, Thompson, Melanie, Podzamczer, Daniel, Molina, Jean Michel, Oka, Shinichi, Koenig, Ellen, Trottier, Benoit, Andrade Villanueva, Jaime, Crofoot, Gordon, Custodio, Joseph M., Plummer, Andrew, Zhong, Lijie, Cao, Huyen, Martin, Hal, Callebaut, Christian, Cheng, Andrew K., Fordyce, Marshall W., Mccallister, Scott, for the GS US 292 0104/0111 Study Team [. . ., VIALE, PIERLUIGI
Publikováno v:
Lancet (London, England). 385(9987)
Background Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations. Tenofovir alafenamide is a novel tenofovir prodrug with a 90% reduction in plasma tenofovir concentrations. Tenofovir ala